Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Adendra Therapeutics logo — Translating dendritic cell biology into new therapies for ca...

Adendra Therapeutics

Translating dendritic cell biology into new therapies for cancer and autoimmunity.

Founded 2021 United Kingdom London, United Kingdom 3 employees Series A Total: $53.00M Biopharma, Biotechnology +1

General Information

Company Name Adendra Therapeutics
Founded Year 2021
Location United Kingdom London, United Kingdom
Founders / Decision Makers
Team member
Employees 3
Industries Biopharma, Biotechnology, Health Care
Funding Stage Series A
Business Model B2B, B2D
Revenue Model Licensing, Product Sales, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with Adendra Therapeutics. To contact Adendra Therapeutics, visit adendratx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Adendra Therapeutics compare?

A PDF of Adendra Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Adendra Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Adendra Therapeutics

Adendra Therapeutics is an innovative player in the biotechnology and biopharma industries, with a mission to revolutionize treatment options for cancer and autoimmune diseases. The company prides itself on its slogan, "Translating dendritic cell biology into new therapies for cancer and autoimmunity," encapsulating its core strategic focus.

Founded in 2021 and headquartered in the United Kingdom, Adendra Therapeutics leverages cutting-edge research to develop new therapeutic drugs. The company's approach focuses on targeting dendritic cell biology, addressing a substantial unmet need in medical treatment options.

In December 2021, the company secured a $53.00M Series A investment led by Apple Tree Partners. This significant financial backing bolsters their ability to advance their promising drug pipeline. Given its innovative approach and strong financial support, Adendra Therapeutics presents an attractive opportunity for investors seeking to capitalize on advancements in health care solutions.

Business keywords: Dendritic Cell Biology, Cancer Therapies, Autoimmune Disease Treatments, Small Molecule Medicines, Biologic Medicines, Immunotherapy, Translational Medicine, Cancer Research, Autoimmunity Research, Therapeutic Development, Pharmaceutical Innovation

Services & Products

Developing treatments for solid tumors
Developing treatments for autoimmune diseases

Target Customers

Cancer Patients Patients with Autoimmune Diseases Healthcare Providers Research Organizations

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A $53.00M 1
Apple Tree Partners
Apple Tree Partners
01 Dec 2021
Spinout Undisclosed 1
Francis Fund
Francis Fund
01 Jan 2021

Adendra Therapeutics Alternatives & Competitors

View All Alternatives
Adendra Therapeutics vs
ROME Therapeutics
ROME Therapeutics United States

Harnessing the power of the repeatome to develop a new class of therapies for cancer and autoimmune...

Acquired
16 employees
Biotechnology, Health Care
Adendra Therapeutics vs
Adaptimmune
Adaptimmune United Kingdom

Designing and delivering cell therapies to transform the lives of people with cancer.

Post-IPO Debt
200 employees
Biopharma, Biotechnology
Adendra Therapeutics vs
Fate Therapeutics Inc.
Fate Therapeutics Inc. United States

Transforming the lives of patients with autoimmune diseases and cancer.

227 employees
Biotechnology, Health Care
Also compare with: Adendra Therapeutics vs Cullinan Therapeutics Cullinan Therapeutics View all alternatives

FAQ About Adendra Therapeutics

Translating dendritic cell biology into new therapies for cancer and autoimmunity.
Adendra Therapeutics was founded in 2021.
Adendra Therapeutics is headquartered in London, United Kingdom.
Adendra Therapeutics operates in Biopharma, Biotechnology and Health Care. Its work centres on Dendritic Cell Biology, Cancer Therapies, Autoimmune Disease Treatments and Small Molecule Medicines. Its customers include Cancer Patients, Patients with Autoimmune Diseases and Healthcare Providers.
Adendra Therapeutics has a B2B and B2D business model. Its revenue comes from Licensing, Product Sales and Service Fee.
Adendra Therapeutics has approximately 3 employees.
Adendra Therapeutics has completed 2 funding rounds, raising a total of $53.00M. The latest funding stage is Series A.
Adendra Therapeutics offers: Developing treatments for solid tumors, Developing treatments for autoimmune diseases.
Top alternatives and competitors to Adendra Therapeutics include ROME Therapeutics, Adaptimmune, Fate Therapeutics Inc., Avenzo Therapeutics, Autolus Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Adendra Therapeutics and ROME Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Adendra Therapeutics, https://bouncewatch.com/company/adendra-therapeutics, updated 22 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes